ExpertiseUpdated on 28 October 2025
Citogenetics and Functional Genomics
Research Manager at Universidade de Coimbra - Faculdade de Coimbra
Coimbra, Portugal
About
-
Development of predictive genomic models for tumor disease progression and survival
-
Liquid biopsies and characterization of dynamic changes in circulating tumor DNA in different oncological pathologies
-
Establishment of primary tumor cell cultures and cytogenomic characterization
-
Genomic and epigenetic characterization of tumor samples: identification of diagnostic and prognostic biomarkers
-
Metagenomics: Investigate the microbiota composition of complex environments.
-
NGS Panels; RNA-seq; SNVs/SNPs identification; Molecular tumour profiling
Field
- Receiver institution with a need to adopt a PM approach
- Screening & early detection programs (risk stratification, predictive tools)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Clinical decision support systems for personalised medicine
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
Organisation
Similar opportunities
Expertise
Advancing Personalized Medicine Through Integrative Research and Clinical Excellence
- Receiver institution with a need to adopt a PM approach
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Partial adoption of a PM solution (testing selected modules/components)
- Tools for secure data sharing & secondary use (pseudonymisation, FAIR data)
- Screening & early detection programs (risk stratification, predictive tools)
- Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
- Cultural/organisational change approaches (staff training, workflow redesign)
- Data integration & interoperability solutions (EHRs, registries, data platforms)
- Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
- Patient engagement & empowerment strategies (self-management tools, shared decision-making)
- Adaptation of an existing PM solution to local context (language, IT environment, regulations)
- Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)
Inês Costa
Research Manager at Universidade de Coimbra - Faculdade de Coimbra
Coimbra, Portugal
Expertise
Advisory services on the implementation of 3D printing technology in public and private hospitals.
- Donor institution with a ready PM approach
- Receiver institution with a need to adopt a PM approach
- Clinical decision support systems for personalised medicine
- Full adoption/acquisition of a PM solution into clinical practice
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Partial adoption of a PM solution (testing selected modules/components)
- Screening & early detection programs (risk stratification, predictive tools)
- Cultural/organisational change approaches (staff training, workflow redesign)
- Reimbursement-ready approaches (integration with public health insurance systems)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
- Patient engagement & empowerment strategies (self-management tools, shared decision-making)
- Adaptation of an existing PM solution to local context (language, IT environment, regulations)
- Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)
Jesús Corbacho
Medical Advisor on 3D Printing Integration in Clinical Environments. at Eureqa 3D
Cáceres, Spain
Expertise
Development and phenotyping of genetically engineered mouse models
- Receiver institution with a need to adopt a PM approach
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
Kasım DİRİL
Principal investigator at Izmir Biomedicine and Genome Center
Izmir, Türkiye